TherapeuticsMD Inc (TXMD)
1.87
-0.05
(-2.60%)
USD |
NASDAQ |
Apr 25, 16:00
1.87
0.00 (0.00%)
After-Hours: 20:00
TherapeuticsMD Free Cash Flow (Quarterly): -4.96M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -4.96M |
| September 30, 2023 | -6.028M |
| June 30, 2023 | -3.392M |
| March 31, 2023 | -8.701M |
| December 31, 2022 | 16.72M |
| September 30, 2022 | 17.72M |
| June 30, 2022 | -20.80M |
| March 31, 2022 | -18.08M |
| December 31, 2021 | -41.07M |
| September 30, 2021 | -38.40M |
| June 30, 2021 | -26.62M |
| March 31, 2021 | -38.82M |
| December 31, 2020 | -30.85M |
| September 30, 2020 | -34.31M |
| June 30, 2020 | -56.35M |
| March 31, 2020 | -39.55M |
| December 31, 2019 | -71.53M |
| September 30, 2019 | -27.52M |
| June 30, 2019 | -51.70M |
| March 31, 2019 | -38.83M |
| December 31, 2018 | -28.65M |
| September 30, 2018 | -54.40M |
| June 30, 2018 | -25.26M |
| March 31, 2018 | -19.82M |
| December 31, 2017 | -21.16M |
| Date | Value |
|---|---|
| September 30, 2017 | -16.76M |
| June 30, 2017 | -18.41M |
| March 31, 2017 | -20.66M |
| December 31, 2016 | -16.01M |
| September 30, 2016 | -18.99M |
| June 30, 2016 | -15.81M |
| March 31, 2016 | -19.57M |
| December 31, 2015 | -17.06M |
| September 30, 2015 | -18.48M |
| June 30, 2015 | -24.90M |
| March 31, 2015 | -19.19M |
| December 31, 2014 | -15.68M |
| September 30, 2014 | -11.44M |
| June 30, 2014 | -10.20M |
| March 31, 2014 | -8.827M |
| December 31, 2013 | -4.967M |
| September 30, 2013 | -5.461M |
| June 30, 2013 | -7.207M |
| March 31, 2013 | -3.612M |
| December 31, 2012 | -4.122M |
| September 30, 2012 | -3.123M |
| June 30, 2012 | -3.269M |
| March 31, 2012 | -2.496M |
| December 31, 2011 | -1.894M |
| September 30, 2011 | -1.522M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-71.53M
Minimum
Dec 2019
17.72M
Maximum
Sep 2022
-25.49M
Average
-27.52M
Median
Sep 2019
Free Cash Flow (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -0.316M |
| Palatin Technologies Inc | -10.51M |
| iBio Inc | -4.706M |
| Theriva Biologics Inc | -6.597M |
| Oragenics Inc | -1.102M |